NATRILIX SR indapamide 1.5mg sustained release tablets (Germany)
Section 19A approved medicine
NATRILIX SR indapamide 1.5mg sustained release tablets (Germany)
Section 19A approval holder
Aborns Pharmaceuticals Pty Ltd ABN: 80 625 808 193
Phone
1300 117 772
Approved until
Status
Current
Medicines in short supply/unavailable
APO-INDAPAMIDE SR indapamide hemihydrate 1.5 mg modified release tablet blister pack ARTG - 208007
Indication(s)
Treatment of hypertension. It may be tried as a sole therapeutic agent in the treatment of hypertension. Normally, indapamide is used as the initial agent in multiple drug regimes.
Images
